ID: ALA5281929

Max Phase: Preclinical

Molecular Formula: C33H46N6O5S

Molecular Weight: 638.84

Representations

Canonical SMILES:  C=C[C@]1(C)C[C@@H](OC(=O)CSc2nc(NC(=O)CN3CCCC3)nc3[nH]cnc23)[C@@]2(C)C3C(=O)CC[C@@]3(CC[C@H]2C)[C@@H](C)[C@@H]1O

Standard InChI:  InChI=1S/C33H46N6O5S/c1-6-31(4)15-22(32(5)19(2)9-11-33(20(3)27(31)43)12-10-21(40)26(32)33)44-24(42)17-45-29-25-28(35-18-34-25)37-30(38-29)36-23(41)16-39-13-7-8-14-39/h6,18-20,22,26-27,43H,1,7-17H2,2-5H3,(H2,34,35,36,37,38,41)/t19-,20+,22-,26?,27+,31-,32+,33+/m1/s1

Standard InChI Key:  YHSWFTTXDQMULP-RKPWQCSBSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 638.84

Molecular Weight (Monoisotopic): 638.3250

AlogP: 4.39

#Rotatable Bonds: 8

Polar Surface Area: 150.40

Molecular Species: NEUTRAL

HBA: 10

HBD: 3

#RO5 Violations: 1

HBA (Lipinski): 11

HBD (Lipinski): 3

#RO5 Violations (Lipinski): 2

CX Acidic pKa: 9.65

CX Basic pKa: 6.79

CX LogP: 3.95

CX LogD: 3.61

Aromatic Rings: 2

Heavy Atoms: 45

QED Weighted: 0.16

Np Likeness Score: 0.53

References

1. Yong C, Yu J, Wu C, Zhang X, Li Y, Xie C, He X, Liu D, Wang Z, Lai P, Zhang Y..  (2023)  Design, Synthesis, and Biological Activity of Thioguanine-Modified Pleuromutilin Derivatives.,  14  (6): [PMID:37312858] [10.1021/acsmedchemlett.3c00004]

Source

Source(1):

• Scientific Literature